Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,119.47
(
-0.76%
)
US TECH 100
26,197.60
(
-1.40%
)
Dow Jones
49,199.91
(
-0.22%
)
Brent Oil
104.33
(
2.17%
)
Bitcoin
75,962.65
(
-1.82%
)
News Focus
News Focus
Post# of 823347
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

newman2021

Send PM Follow Ignore
Followers 31
Posts 5433
Boards Moderated 0
Alias Born 10/05/2021

newman2021

Re: CaptainObvious post# 438356

Tuesday, 01/25/2022 1:12:46 PM

Tuesday, January 25, 2022 1:12:46 PM

Post# of 823347
yep, very interesting isn't it. If you assign a 14month mOS for rGBM from DcVaxL trial and compare it with the ECs that fall in line with an mOS of 7 months, of course a 100% improvement which is a second home run to Pazdur, imo. Recall 2018 JTM paper showed an 23months mOS blended that included the crossover or rGBM patients. Bingo!!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News